Microangiopathic hemolytic anemia due to ADAMTS-13 loss in idiopathic systemic capillary leak syndrome

D C Moreira1, C J Ng1, R Quinones1

  • 1Department of Pediatrics, University of Colorado Anschutz Medical Campus (AMC), Aurora, CO, USA.

Insights

Systemic capillary leak syndrome (SCLS) can lead to microangiopathic hemolytic anemia (MAHA). This rare anemia may result from ADAMTS-13 enzyme loss into extravascular fluid spaces during SCLS episodes.

Area of Science:

  • Hematology
  • Vascular Biology
  • Rare Diseases

Background:

  • Idiopathic systemic capillary leak syndrome (SCLS) is a rare disorder characterized by recurrent episodes of severe vascular leakage, leading to hypotension, hypoalbuminemia, hemoconcentration, and edema.
  • While anemia and thrombocytopenia are not typical features of SCLS, this case highlights a potential complication.

Observation:

  • A pediatric patient presenting with SCLS developed microangiopathic hemolytic anemia (MAHA) during a phase of significant fluid extravasation and anasarca.
  • Serial measurements of ADAMTS-13 activity were performed during the clinical course.

Findings:

  • The study proposes a novel mechanism for acquired MAHA in SCLS.
  • ADAMTS-13 loss into the extravascular 'third-space' fluid is hypothesized to cause MAHA in this patient.
  • This suggests that significant protein extravasation in SCLS can lead to conditions conducive to MAHA.

Implications:

  • This finding expands the spectrum of potential complications associated with SCLS.
  • It suggests a new pathway for the development of acquired MAHA, linked to severe protein leakage.
  • Further research may elucidate the precise mechanisms and clinical significance of ADAMTS-13 deficiency in SCLS-associated MAHA.

Related Concept Videos

Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
85
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
687
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.6K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
821